Sedative and cardiorespiratory effects of dexmedetomidine and buprenorphine administered to cats via oral transmucosal or intramuscular routes.

OBJECTIVE To determine if buprenorphine plus dexmedetomidine administered via the oral transmucosal route produces sufficient sedation in cats so that students can insert intravenous catheters. STUDY DESIGN Prospective, randomized, blinded, clinical trial. ANIMALS Eighty-seven shelter-owned female cats aged 4-48 months, weighing 1.1-4.9 kg. METHODS Cats were randomly allocated to two treatment groups based on route of drug administration: oral transmucosal (OTM), or intramuscular (IM). Buprenorphine (20 microg kg(-1)) plus dexmedetomidine (20 microg kg(-1)) were administered as pre-medicants via one of these two routes. Prior to and 20 minutes after drug administration, heart and respiratory rates, systolic arterial pressure, and posture were measured and recorded. Twenty minutes after drug administration the same variables plus each cat's response to clipper sound, clipping, and restraint were recorded; higher scores indicated more sedation. RESULTS There were no significant differences between the two groups prior to pre-medication. Within each treatment group heart rate was significantly lower 20 minutes after treatment, but it did not differ significantly between the two groups. Twenty minutes after treatment, respiratory rate was significantly less in the OTM group, but did not differ significantly between the two groups. Systolic arterial pressure did not differ within or between the two groups at either time. Scores for posture increased significantly within both groups, and cats in the IM group had higher scores after treatment. Twenty minutes after treatment, cats in the IM group had higher scores for clipping and restraint than OTM cats. Ketamine (IM) was necessary to facilitate catheterization in 25% and 16% of cats in the OTM and IM groups, respectively, but this was not significantly different. CONCLUSIONS AND CLINICAL RELEVANCE Administration of dexmedetomidine plus buprenorphine by the OTM route is easy to perform, but produces less sedation than the IM route for IV catheterization in cats.

[1]  P. Taylor,et al.  Thermal antinociception after dexmedetomidine administration in cats: A comparison between intramuscular and oral transmucosal administration , 2009, Journal of feline medicine and surgery.

[2]  A. Aguiar,et al.  Sedative and cardiorespiratory effects of acepromazine or atropine given before dexmedetomidine in dogs , 2008, Veterinary Record.

[3]  T. Germann,et al.  Reversibility of opioid receptor occupancy of buprenorphine in vivo. , 2006, European journal of pharmacology.

[4]  J. Sear,et al.  PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration. , 2005, Journal of veterinary pharmacology and therapeutics.

[5]  Jeffrey A. Roberts,et al.  FOUR PREANESTHETIC ORAL SEDATION PROTOCOLS FOR RHESUS MACAQUES (MACACA MULATTA) , 2004, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

[6]  P. Taylor,et al.  Pain management in cats—past, present and future. Part 2. Treatment of pain—clinical pharmacology , 2004, Journal of feline medicine and surgery.

[7]  O. B. Ansah.  Use of the alpha-2-adrenoceptor agonists medetomidine and dexmedetomidine in the sedation and analgesia of domestic cats , 2004 .

[8]  J. W. Carpenter,et al.  CLINICAL EFFECTS AND PLASMA CONCENTRATIONS OF FENTANYL AFTER TRANSMUCOSAL ADMINISTRATION IN THREE SPECIES OF GREAT APE , 2004, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

[9]  J. Cupitt,et al.  Pain and intramuscular injections , 2004, Anaesthesia.

[10]  P. Taylor,et al.  Changes in thermal threshold response in eight cats after administration of buprenorphine, butorphanol and morphine , 2003, Veterinary Record.

[11]  J. Sear,et al.  Systemic uptake of buprenorphine by cats after oral mucosal administration , 2003, Veterinary Record.

[12]  J. Sear,et al.  Morphine, pethidine and buprenorphine disposition in the cat. , 2002, Journal of veterinary pharmacology and therapeutics.

[13]  O. Vainio,et al.  Comparison of medetomidine and dexmedetomidine as premedicants in dogs undergoing propofol-isoflurane anesthesia. , 2001, American journal of veterinary research.

[14]  E. Ramsay,et al.  Sedative and physiologic effects of orally administered alpha 2-adrenoceptor agonists and ketamine in cats. , 2000, Journal of the American Veterinary Medical Association.

[15]  B. Swenson,et al.  ORAL INDUCTION OF ANESTHESIA WITH DROPERIDOL AND TRANSMUCOSAL CARFENTANIL CITRATE IN CHIMPANZEES (PAN TROGLODYTES) , 2000, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

[16]  Judith E. Hall,et al.  Sedative, Amnestic, and Analgesic Properties of Small-Dose Dexmedetomidine Infusions , 2000, Anesthesia and analgesia.

[17]  A. Waterman-Pearson,et al.  Current British veterinary attitudes to perioperative analgesia for cats and small mammals , 1999, Veterinary Record.

[18]  M Raekallio,et al.  Comparison of three doses of dexmedetomidine with medetomidine in cats following intramuscular administration. , 1998, Journal of veterinary pharmacology and therapeutics.

[19]  A. Waterman-Pearson,et al.  Comparison of pethidine, buprenorphine and ketoprofen for postoperative analgesia after ovariohysterectomy in the cat , 1998, Veterinary Record.

[20]  S. Cantwell,et al.  A comparison of indirect blood pressure monitoring techniques in the anesthetized cat. , 1998, Veterinary surgery : VS.

[21]  E. Martinez,et al.  Cardiovascular effects of buprenorphine in anesthetized dogs. , 1997, American journal of veterinary research.

[22]  H. Kotaki,et al.  Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine. , 1997, The Journal of pharmacology and experimental therapeutics.

[23]  Reese T. Jones,et al.  Bioavailability of Sublingual Buprenorphine , 1997, Journal of clinical pharmacology.

[24]  D. Church,et al.  Use of anti-inflammatory and analgesic drugs in dogs and cats. , 1996, Australian veterinary journal.

[25]  J. Kampine,et al.  Oral Dexmedetomidine Preserves Baroreceptor Function and Decreases Anesthetic Requirements of Halothane‐anesthetized Dogs , 1994, Anesthesiology.

[26]  E. P. Smith,et al.  Cardiorespiratory effects of four opioid-tranquilizer combinations in dogs. , 1994, Veterinary surgery : VS.

[27]  T. Duke,et al.  The cardiopulmonary effects of placing fentanyl or medetomidine in the lumbosacral epidural space of isoflurane-anesthetized cats. , 1994, Veterinary surgery : VS.

[28]  M. Littman.  Spontaneous systemic hypertension in 24 cats. , 1994, Journal of veterinary internal medicine.

[29]  B. C. Bloor,et al.  Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. , 1992, Anesthesiology.

[30]  M. Scheinin,et al.  Comparison of the behavioral and neurochemical effects of the two optical enantiomers of medetomidine, a selective alpha-2-adrenoceptor agonist. , 1991, The Journal of pharmacology and experimental therapeutics.

[31]  M. Peterson,et al.  Hypertension in cats with chronic renal failure or hyperthyroidism. , 1990, Journal of veterinary internal medicine.

[32]  O. Vainio,et al.  Cardiovascular and Respiratory Effects of Medetomidine in Dogs and Influence of Anticholinergics , 1989, Acta Veterinaria Scandinavica.

[33]  T. Vähä-Vahe.  Clinical Evaluation of Medetomidine, a Novel Sedative and Analgesic Drug for Dogs and Cats , 1989, Acta Veterinaria Scandinavica.

[34]  O. Vainio,et al.  Sedative and analgesic effects of medetomidine in dogs. , 1989, Journal of veterinary pharmacology and therapeutics.

[35]  M. Scheinin,et al.  Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative. , 1988, European journal of pharmacology.

[36]  K. Foley,et al.  Sublingual absorption of selected opioid analgesics , 1988, Clinical pharmacology and therapeutics.

[37]  J. Villiger,et al.  Clinical actions of fentanyl and buprenorphine. The significance of receptor binding. , 1985, British journal of anaesthesia.

[38]  D. Scott,et al.  Haemodynamic changes following buprenorphine and morphine , 1980, Anaesthesia.

[39]  A. Cowan,et al.  THE ANIMAL PHARMACOLOGY OF BUPRENORPHINE, AN ORIPAVINE ANALGESIC AGENT , 1977, British journal of pharmacology.

[40]  H. Erb,et al.  Pharmacokinetics of buccal mucosal administration of fentanyl in a carboxymethylcellulose gel compared with IV administration in dogs. , 2008, Veterinary therapeutics : research in applied veterinary medicine.

[41]  L. Maxwell,et al.  Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs. , 2008, Veterinary therapeutics : research in applied veterinary medicine.

[42]  B. Lins,et al.  Evaluation of the sedative and cardiorespiratory effects of dexmedetomidine, dexmedetomidine-butorphanol, and dexmedetomidine-ketamine in cats. , 2003, Journal of the American Veterinary Medical Association.

[43]  P. Taylor,et al.  A preliminary investigation comparing pre-operative morphine and buprenorphine for postoperative analgesia and sedation in cats. , 2002, Veterinary anaesthesia and analgesia.

[44]  Savola Jm,et al.  Cardiovascular actions of medetomidine and their reversal by atipamezole. , 1989 .